Aspiriant LLC’s iShares Core MSCI International Developed Markets ETF IDEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.25M Buy
110,712
+7,986
+8% +$687K 0.26% 45
2025
Q4
$8.47M Buy
+102,726
New +$8.35M 0.24% 49

Other funds holding IDEV

Aspiriant LLC's IDEV Position: Q1 2026 in Review

Aspiriant LLC increased its iShares Core MSCI International Developed Markets ETF (IDEV) stake by 7.8% in Q1 2026, buying an estimated $687K and bringing the position to 110,712 shares worth $9.25M. The position accounts for 0.26% of the portfolio, ranked #45.

Aspiriant LLC first reported a position in IDEV in Q4 2025 and has held it in 2 quarters since. 706 funds tracked by Wall St. Rank hold IDEV as of Q1 2026.

  • Aspiriant LLC held 110,712 shares of iShares Core MSCI International Developed Markets ETF worth $9.25M as of Q1 2026.
  • Aspiriant LLC bought 7,986 iShares Core MSCI International Developed Markets ETF shares in Q1 2026, an estimated $687K.
  • iShares Core MSCI International Developed Markets ETF made up 0.26% of Aspiriant LLC's portfolio in Q1 2026, its #45 holding.
  • Aspiriant LLC first reported a position in iShares Core MSCI International Developed Markets ETF in Q4 2025 and has held it in 2 quarters since.
  • 706 funds tracked by Wall St. Rank held iShares Core MSCI International Developed Markets ETF as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.